Jarislowsky, Fraser Ltd’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$2.77M Sell
36,771
-1,309
-3% -$89.7K 0.02% 118
2025
Q2
$2.63M Sell
38,080
-315
-0.8% -$20.7K 0.02% 120
2025
Q1
$2.6M Sell
38,395
-3,000
-7% -$180K 0.02% 119
2024
Q4
$1.86M Sell
41,395
-2,650
-6% -$149K 0.01% 125
2024
Q3
$2.77M Sell
44,045
-36,000
-45% -$2.1M 0.02% 117
2024
Q2
$4.73M Sell
80,045
-14,500
-15% -$907K 0.03% 105
2024
Q1
$7.54M Sell
94,545
-10,885
-10% -$831K 0.04% 96
2023
Q4
$8.32M Sell
105,430
-4,784
-4% -$340K 0.05% 91
2023
Q3
$7.7M Sell
110,214
-2,045
-2% -$145K 0.05% 92
2023
Q2
$7.76M Sell
112,259
-7,425
-6% -$528K 0.05% 95
2023
Q1
$8.89M Sell
119,684
-6,030
-5% -$506K 0.05% 92
2022
Q4
$11.7M Sell
125,714
-5,154
-4% -$497K 0.08% 90
2022
Q3
$12.5M Sell
130,868
-1,851
-1% -$183K 0.09% 88
2022
Q2
$12.3M Sell
132,719
-1,700
-1% -$166K 0.08% 90
2022
Q1
$13.6M Sell
134,419
-3,125
-2% -$328K 0.07% 88
2021
Q4
$14.2M Sell
137,544
-33,870
-20% -$3.13M 0.07% 89
2021
Q3
$14.5M Sell
171,414
-7,350
-4% -$616K 0.07% 87
2021
Q2
$14.9M Sell
178,764
-38,108
-18% -$3.12M 0.07% 88
2021
Q1
$16.3M Sell
216,872
-52,345
-19% -$3.81M 0.08% 80
2020
Q4
$18.4M Sell
269,217
-46,212
-15% -$3.01M 0.09% 76
2020
Q3
$18.4M Sell
315,429
-26,349
-8% -$1.64M 0.11% 72
2020
Q2
$22.2M Sell
341,778
-24,471
-7% -$1.54M 0.14% 71
2020
Q1
$21.7M Sell
366,249
-57,730
-14% -$3.85M 0.16% 70
2019
Q4
$31.5M Sell
423,979
-77,442
-15% -$5.44M 0.17% 73
2019
Q3
$31.6M Sell
501,421
-172,108
-26% -$10.2M 0.18% 67
2019
Q2
$36.7M Sell
673,529
-859,910
-56% -$46.3M 0.22% 64
2019
Q1
$82.7M Sell
1,533,439
-149,770
-9% -$9.24M 0.52% 44
2018
Q4
$110M Buy
1,683,209
+166,072
+11% +$12.4M 0.76% 37
2018
Q3
$110M Sell
1,517,137
-220,950
-13% -$15.8M 0.68% 41
2018
Q2
$112M Buy
1,738,087
+31,074
+2% +$2.05M 0.67% 38
2018
Q1
$106M Buy
1,707,013
+83,382
+5% +$5.98M 0.66% 38
2017
Q4
$118M Buy
1,623,631
+46,933
+3% +$3.41M 0.68% 36
2017
Q3
$128M Sell
1,576,698
-3,268
-0.2% -$259K 0.77% 29
2017
Q2
$127M Sell
1,579,966
-13,915
-0.9% -$1.1M 0.8% 30
2017
Q1
$125M Sell
1,593,881
-40,637
-2% -$3.24M 0.79% 33
2016
Q4
$129M Buy
1,634,518
+115,421
+8% +$9.34M 0.83% 34
2016
Q3
$135M Sell
1,519,097
-39,679
-3% -$3.75M 0.91% 30
2016
Q2
$149M Sell
1,558,776
-46,133
-3% -$4.6M 1.04% 26
2016
Q1
$166M Sell
1,604,909
-27,922
-2% -$2.71M 1.16% 24
2015
Q4
$160M Sell
1,632,831
-44,697
-3% -$4.38M 1.21% 26
2015
Q3
$162M Sell
1,677,528
-4,223
-0.3% -$444K 1.22% 23
2015
Q2
$176M Sell
1,681,751
-10,344
-0.6% -$1.06M 1.2% 23
2015
Q1
$175M Sell
1,692,095
-111,651
-6% -$11.3M 1.17% 22
2014
Q4
$174M Sell
1,803,746
-54,945
-3% -$4.84M 1.07% 25
2014
Q3
$148M Sell
1,858,691
-63,890
-3% -$5.04M 0.89% 28
2014
Q2
$145M Sell
1,922,581
-80,393
-4% -$6.08M 0.81% 30
2014
Q1
$150M Sell
2,002,974
-59,901
-3% -$4.23M 0.87% 30
2013
Q4
$148M Sell
2,062,875
-46,057
-2% -$2.96M 0.83% 33
2013
Q3
$120M Sell
2,108,932
-58,400
-3% -$3.48M 0.7% 32
2013
Q2
$124M Buy
+2,167,332
New +$126M 0.75% 33

Other funds holding CVS

Jarislowsky, Fraser Ltd's CVS Position: Q3 2025 in Review

Jarislowsky, Fraser Ltd reduced its CVS Health (CVS) stake by 3.4% in Q3 2025, selling an estimated $89.7K and leaving 36,771 shares worth $2.77M. The position accounts for 0.02% of the portfolio, ranked #118.

Jarislowsky, Fraser Ltd first reported a position in CVS in Q2 2013 and has held it in 50 quarters since. The position peaked at $176M in Q2 2015. 1,835 funds tracked by Wall St. Rank hold CVS as of Q3 2025.

  • Jarislowsky, Fraser Ltd held 36,771 shares of CVS Health worth $2.77M as of Q3 2025.
  • Jarislowsky, Fraser Ltd sold 1,309 CVS Health shares in Q3 2025, an estimated $89.7K.
  • CVS Health made up 0.02% of Jarislowsky, Fraser Ltd's portfolio in Q3 2025, its #118 holding.
  • Jarislowsky, Fraser Ltd first reported a position in CVS Health in Q2 2013 and has held it in 50 quarters since.
  • Jarislowsky, Fraser Ltd's CVS Health position peaked at $176M in Q2 2015.
  • 1,835 funds tracked by Wall St. Rank held CVS Health as of Q3 2025.

Based on Jarislowsky, Fraser Ltd's 13F filing for Q3 2025, filed 21 Oct 2025.